Sequencing and array-based solutions for analysis of genetic variation and function
Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
Visit website: https://www.illumina.com/
People at Illumina
Illumina reunites with cancer testing firm Grail, worth $8 billion deal
FierceBiotech - 21-Sep-2020
Marks new era in advancing screening and early diagnosis of cancer technologyRead more...
Thrive’s CancerSEEK uses blood tests for early multi-cancer detection
Endpoints News - 28-Apr-2020
Demonstrated in a large prospective study involving patients without cancer historyRead more...
Illumina aiming to deliver $100 Genome Sequencing
Lifespan.io (LEAF) - 05-Mar-2020
Not here yet, but will expand research capabilities and change the way medicine is practicedRead more...